Conservation of binding epitopes for Monoclonal Antibodies on the rabies virus glycoprotein

Journal of Antivirals and Antiretrovirals

Volumn 5, Issue 2, 2013, Pages 037-043

  Kuzmina, Natalia A ^a   Kuzmin, Ivan V ^a,b   Ellison, James A ^a   Rupprecht, Charles E ^a,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Aravan LLC   (United States)

^c Erasmus Forum A434   (United States)

Author keywords

Antigenic site; Binding epitopes; Glycoprotein; Monoclonal antibody; Post exposure prophylaxis; Rabies virus; Sequence

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; RAB PROTEIN; RABIES IMMUNOGLOBULIN;

ARTICLE; BAT; BAYES THEOREM; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; RABIES VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EQUIDAE; RABIES VIRUS;

EID: 84876938669     PISSN: None     EISSN: 19485964     Source Type: Journal    
DOI: 10.4172/jaa.1000061     Document Type: Article

References (42)

1. Rupprecht CE, Turmelle A, Kuzmin IV (2011) A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol 1: 662-670.
2. Knobel DL, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, et al. (2005) Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83: 360-368.
3. Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, et al. (2008) Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 57: 1-28.
4. Noah DL, Smith MG, Gotthardt JC, Krebs JW, Green D, et al. (1996) Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am J Public Health 86: 1149-1151.
5. Rotz LD, Rupprecht CE (1999) Rabies. In: Conn's current therapy, Rakel RE, Saunders, Philadelphia, 122-125.
6. Lang J, Attanath P, Quiambao B, Singhasivanon V, Chanthavanich P, et al. (1998) Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. Acta Trop 70: 317-333.
7. WHO (2004) WHO Technical Report Series 931, WHO expert consultation on rabies: first report. World Health Organization, Geneva, Switzerland.
8. Dietzschold B, Gore M, Casali P, Ueki Y, Rupprecht CE, et al. (1990) Biological characterization of human monoclonal antibodies to rabies virus. J Virol 64: 3087-3090.
9. Enssle K, Kurrle R, Köhler R, Müller H, Kanzy EJ, et al. (1991) A rabiesspecific human monoclonal antibody that protects mice against lethal rabies. Hybridoma 10: 547-556.
10. Hanlon CA, DeMattos CA, DeMattos CC, Niezgoda M, Hooper DC, et al. (2001) Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis. Vaccine 19: 3834-3842.
11. Montaño-Hirose JA, Lafage M, Weber P, Badrane H, Tordo N, et al. (1993) Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice. Vaccine 11: 1259-1266.
12. Prosniak M, Faber M, Hanlon CA, Rupprecht CE, Hooper DC, et al. (2003) Development of a cocktail of recombinant-expressed human rabies virusneutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Infect Dis 188: 53-56.
13. Schumacher CL, Dietzschold B, Ertl HC, Niu HS, Rupprecht CE, et al. (1989) Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest 84: 971-975.
14. Müller T, Dietzschold B, Ertl H, Fooks AR, Freuling C, et al. (2009) Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl Trop Dis 3: e542.
15. Lafon M (2005) Rabies virus receptors. J Neurovirol 11: 82-87.
16. Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, et al. (2005) Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 79: 4672-4678.
17. Prehaud C, Coulon P, LaFay F, Thiers C, Flamand A (1988) Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol 62: 1-7.
18. Bunschoten H, Gore M, Claassen IJ, Uytdehaag FG, Dietzschold B, et al. (1989) Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J Gen Virol 70: 291-298.
19. Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, et al. (1991) Antigenicity of rabies virus glycoprotein. J Virol 65: 4198-4203.
20. Wunner WH (2007) Rabies virus. In: Rabies, Jackson AC, Wunner WH, 2nd Edition, Elsevier-Acad Press, London, 23-68.
21. Bakker AB, Marissen WE, Kramer RA, Rice AB, Weldon WC, et al. (2005) Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J Virol 79: 9062-9068.
22. Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, et al. (2006) Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J Infect Dis 193: 796-801.
23. Wang Y, Rowley KJ, Booth BJ, Sloan SE, Ambrosino DM, et al. (2011) G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates. Antiviral Res 91: 187-194.
24. Sloan SE, Hanlon C, Weldon W, Niezgoda M, Blanton J, et al. (2007) Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 25: 2800-2810.
25. Gogtay N, Thatte U, Kshirsagar N, Leav B, Molrine D, et al. (2012) Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults. Vaccine 30: 7315-7320.
26. Both L, van Dolleweerd C, Wright E, Banyard AC, Bulmer-Thomas B, et al. (2013) Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. FASEB J.
27. Cai K, Feng JN, Wang Q, Li T, Shi J, et al. (2010) Fine mapping and interaction analysis of a linear rabies virus neutralizing epitope. Microbes Infect 12: 948-955.
28. Matsumoto T, Yamada K, Noguchi K, Nakajima K, Takada K, et al. (2010) Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus. Microbiol Immunol 54: 673-683.
29. Muhamuda K, Madhusudana SN, Ravi V (2007) Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies. Hum Vaccin 3: 192-195.
30. Sun L, Chen Z, Yu L, Wei J, Li C, et al. (2012) Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein. Appl Microbiol Biotechnol 96: 357-366.
31. Kuzmin IV, Orciari LA, Arai YT, Smith JS, Hanlon CA, et al. (2003) Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. Virus Res 97: 65-79.
32. Sacramento D, Bourhy H, Tordo N (1991) PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus. Mol Cell Probes 5: 229-240.
33. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41: 95-98.
34. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
35. Franka R, Rupprecht CE (2011) Treatment of rabies in the 21st century: curing the incurable? Future Microbiol 6: 1135-1140.
36. Smith TG, Wu X, Franka R, Rupprecht CE (2011) Design of future rabies biologics and antiviral drugs. Adv Virus Res 79: 345-363.
37. Hanlon CA, Niezgoda M, Rupprecht CE (2002) Postexposure prophylaxis for prevention of rabies in dogs. Am J Vet Res 63: 1096-1100.
38. Wilde H, Choomkasien P, Hemachudha T, Supich C, Chutivongse S (1989) Failure of rabies postexposure treatment in Thailand. Vaccine 7: 49-52.
39. Wilde H, Sirikawin S, Sabcharoen A, Kingnate D, Tantawichien T, et al. (1996) Failure of postexposure treatment of rabies in children. Clin Infect Dis 22: 228-232.
40. Hemachudha T, Wacharapluesadee S, Laothamatas J, Wilde H (2006) Rabies. Curr Neurol Neurosci Rep 6: 460-468.
41. Simmons NB (2005) Order Chiroptera. In: Mammal species of the world: a taxonomic and geographic reference, 3rd edition, Wilson DE, Reeder DM, Volume 12, Johns Hopkins University Press, 312-529.
42. Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, et al. (2008) First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 26: 5922-5927.